CLINICAL_TRIALS
trial_result
· 2021-09-22
Clinical Trial Update: A Study of LY2140023 in Hepatically-Impaired Participants [Phase 1]
Summary
Phase 1 trial update of LY2140023 in participants with hepatic impairment has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Denovo Biopharma LLC | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2021-09-22